Search

Search Results
Results 7251 - 7260 of 7269 for parkinson
  • Drug - 13 Feb 2020
    Consumer Medicine Information (CMI) about Lamisil Tablets (terbinafine) intended for persons living in Australia.
  • Drug - 19 Oct 2017
    Consumer Medicine Information (CMI) about Kytril Injection (granisetron hydrochloride) intended for persons living in Australia.
  • Drug - 19 Oct 2017
    Consumer Medicine Information (CMI) about Kytril Tablets (granisetron hydrochloride) intended for persons living in Australia.
  • Drug - 2 Jul 2024
    Consumer Medicine Information (CMI) about Clopine intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Clozaril intended for persons living in Australia.
  • Supplier - 11 Mar 2021
    Sino Biological is an international reagent supplier and service provider. The company specializes in recombinant protein production and antibody development.
  • Supplier - 15 Oct 2024
    We're developing new medicines for Alzheimer's and Parkinson's disease.
  • Supplier - 22 Sep 2021
    Vincere develops small molecule therapeutics to improve mitochondrial quality. Natural mechanisms of mitochondrial quality control decline with age, leading to the neurodegeneration seen in...
  • Supplier - 14 Nov 2018
    APDM’s mission is to develop and commercialize best-in-class solutions for quantifying human movement with wearable technologies.
  • Supplier - 4 Jan 2024
    PharmaKure, a clinical stage pharmaceutical company is targeting neurodegenerative diseases including Alzheimer’s and Parkinson’s Diseases and other rare diseases. The company’s...

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.